XML 38 R23.htm IDEA: XBRL DOCUMENT v3.6.0.2
Segment Information (Tables)
6 Months Ended
Dec. 31, 2016
Segment Reporting [Abstract]  
Schedule of segment performance measures

Six Months Ended December 31, 2016 and 2015:

 

    Human
Health
    Pharmaceutical
Ingredients
    Performance
Chemicals
    Unallocated
Corporate
    Consolidated
Totals
 
2016                                        
Net sales   $ 101,870     $ 77,432     $ 74,268     $ -     $ 253,570  
Gross profit     31,124       12,612       17,908       -       61,644  
Income (loss) before income taxes     8,905       4,263       8,565       (15,887 )     5,846  
                                         
2015                                        
Net sales   $ 116,526     $ 72,655     $ 75,993     $ -     $ 265,174  
Gross profit     42,047       12,222       16,180       -       70,449  
Income (loss) before income taxes     21,297       3,781       6,804       (3,806 )     28,076  

 

Three months Ended December 31, 2016 and 2015:

 

    Human
Health
    Pharmaceutical
Ingredients
    Performance
Chemicals
    Unallocated
Corporate
    Consolidated
Totals
 
2016                                        
Net sales   $ 53,981     $ 36,816     $ 34,755     $ -     $ 125,552  
Gross profit     16,919       5,658       8,228       -       30,805  
(Loss) income before income taxes     4,933       1,196       3,733       (10,796 )     (934 )
                                         
2015                                        
Net sales   $ 59,045     $ 34,295     $ 38,334     $ -     $ 131,674  
Gross profit     21,738       6,108       8,022       -       35,868  
Income (loss) before income taxes     10,794       1,682       3,260       (2,643 )     13,093